Life expectancy gaps in the United States have widened dramatically over the past two decades, with disparities across racial ...

Panelists discuss how distinct safety profiles among Bruton tyrosine kinase (BTK) inhibitors—including variations in cardiovascular effects, bleeding risk, infection susceptibility, and other adverse ...

Panelists discuss how real-world data on the incidence of cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome (ICANS) compare with clinical trial findings as ...

Panelist discusses how rapid access clinics could revolutionize HS patient care by providing swift, comprehensive diagnostic pathways, integrating multidisciplinary expertise, and enabling early ...

Panelists discuss key strategies for preventing cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome (ICANS) in patients receiving bispecific therapies for B-cell ...

On this episode of Managed Care Cast, we speak with the author of a study published in the January 2025 issue of The American Journal of Managed Care® to examine the association between quantitative ...

Panelists discuss how industry-provided patient support services can assist patients receiving bispecific antibodies, particularly in monitoring and follow-up care, and how these services can support ...

Nearly half of patients with advanced ovarian cancer treated with first-line poly-ADP-ribose polymerase (PARP) inhibitors experienced recurrence in this real-world study, emphasizing the need for ...

Panelists discuss how they envision the future of industry-provided and other patient support services in hematology-oncology, highlighting potential improvements and innovations that could be ...

Children born in spring or summer with a specific gene variant may have a higher risk of celiac disease and lower levels of a key protein, according to a study, potentially helping future research on ...

Researchers suspect unmet treatment needs contribute to the shorter life expectancy for patients living with attention-deficit/hyperactivity disorder (ADHD).

These findings may offer more personalized treatment and prevention recommendations for patients with psoriasis.